MedTech News
.................... by Andrew Celentano
Injectable antenna could safely power deep-tissue medical implants
The technology would allow battery-free, minimally invasive, scalable bioelectronic implants such as pacemakers, neuromodulators, and body process monitors.
A new clue to ALS and FTD: Faulty protein disrupts brain’s ‘brake’ system
Findings point to promising drug that restores neuron balance and may slow disease progression
CMS grants NCD for renal denervation, benefiting Medtronic, Recor
National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained FDA approval in 2023.
FastWave Medical reports first-in-human findings for Sola laser IVL system
FastWave Medical today announced new first-in-human and pre-clinical data for its Sola coronary laser intravascular lithotripsy (L-IVL) system.
FDA Grants Clearance for the First-Ever Technology to Measure “Internal” Mobility in Teeth — Generally Associated with Cracks and Loose Restorations
REDMOND, Wash., Oct. 28, 2025 /PRNewswire/ — Perimetrics, Inc., a dental technology company pioneering quantitative diagnostics, announced today that the U.S. Food and Drug Administration (FDA) has granted clearance for the InnerView® System — the first FDA-cleared technology designed to measure both internal and external mobility in teeth and implants.
AI models help pinpoint key neoantigens for personalized skin cancer vaccines
In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that contain features of good candidates for a vaccine.
New clinical tool can measure severity of debilitating skin disorders
A new clinical tool may improve how physicians assess the severity of a painful and often debilitating skin disorder, according to a study recently published in JAMA Dermatology.
Light-based tool continuously monitors vaccine quality during production
A team of researchers at Purdue University and Merck & Co. Inc., known as Merck Sharp & Dohme Corp. outside of the U.S. and Canada, has now introduced a new analytical tool that could help pharmaceutical companies boost vaccine production with rapid monitoring and analysis.